Sagilia 1 mg tablete
| Name | Sagilia 1 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-184246775 |
| Active Substance | razagilintartarat |
| Composition | svaka tableta sadrži 1 mg razagilina (u obliku razagilintartarata) |
| Pharmaceutical Form | tableta |
| Manufacturer | Medochemie Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
| Marketing Authorisation Date | 11.03.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/17 |
| Registration Number | 381-12-01/38-20-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N04BD02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
